Marcus Maurer Selected Research

Schnitzler Syndrome

1/2021	Tocilizumab treatment in patients with Schnitzler syndrome: An open-label study.
1/2020	Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome.
4/2017	Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcus Maurer Research Topics

Disease

114	Chronic Urticaria 12/2024 - 06/2008
86	Urticaria (Hives) 12/2024 - 01/2007
44	Hereditary Angioedemas 12/2023 - 04/2010
42	Angioedema 02/2024 - 06/2008
24	Hypersensitivity (Allergy) 04/2024 - 08/2003
22	Inflammation (Inflammations) 01/2024 - 12/2004
18	Chronic Inducible Urticaria 02/2024 - 01/2014
18	Cold Urticaria 03/2023 - 03/2009
16	Pruritus (Itching) 01/2021 - 08/2006
14	Anaphylaxis (Anaphylactic Shock) 11/2023 - 10/2009
14	Asthma (Bronchial Asthma) 11/2023 - 03/2009
13	Atopic Dermatitis (Atopic Eczema) 01/2023 - 01/2010
11	Allergic Rhinitis 01/2024 - 04/2010
9	COVID-19 11/2023 - 01/2020
9	Familial dermographism 01/2023 - 01/2011
7	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 07/2021
7	Infections 08/2023 - 06/2007
7	Skin Diseases (Skin Disease) 01/2023 - 12/2016
6	Prurigo 01/2023 - 03/2013
6	Contact Dermatitis (Eczema, Contact) 07/2021 - 08/2003
5	Mastocytosis 11/2023 - 12/2012
5	Vasculitis (Vasculitides) 10/2022 - 09/2013
5	Solar Urticaria 01/2022 - 01/2011
3	Rhinitis 01/2024 - 04/2010
3	Cutaneous Mastocytosis 11/2023 - 07/2007
3	Rare Diseases (Rare Disease) 09/2023 - 12/2012
3	Eczema 12/2022 - 12/2014
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2015
3	Schnitzler Syndrome 01/2021 - 04/2017
3	Neoplasms (Cancer) 01/2020 - 03/2014
3	Necrosis 01/2017 - 01/2012
2	Pain (Aches) 06/2023 - 01/2019
2	Bites and Stings (Sting) 06/2023 - 11/2014
2	Body Weight (Weight, Body) 01/2023 - 01/2018
2	Rhinosinusitis 01/2023 - 07/2014
2	Nasal Polyps (Nasal Polyp) 01/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

79	Omalizumab (Xolair)FDA Link 12/2024 - 09/2010
43	Histamine Antagonists (Antihistamines)IBA 12/2024 - 03/2009
35	Immunoglobulin E (IgE)IBA 12/2023 - 07/2009
21	Cholinergic Agents (Cholinergics)IBA 04/2024 - 02/2014
17	Histamine (Histamine Dihydrochloride)FDA Link 02/2024 - 06/2008
16	CytokinesIBA 12/2023 - 08/2006
13	BradykininIBA 01/2023 - 04/2010
13	icatibantIBA 01/2022 - 04/2010
12	AllergensIBA 10/2023 - 08/2003
12	AutoantibodiesIBA 05/2023 - 04/2011
11	Immunoglobulin G (IgG)IBA 11/2023 - 04/2015
10	lanadelumabIBA 09/2023 - 11/2018
8	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2024 - 09/2015
8	Tryptases (Tryptase)IBA 11/2023 - 10/2009
8	rupatadineIBA 08/2023 - 01/2010
8	anti-IgE antibodiesIBA 12/2019 - 07/2007
7	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 01/2024 - 10/2008
7	ligelizumabIBA 11/2023 - 10/2019
7	Monoclonal AntibodiesIBA 01/2023 - 01/2018
6	dupilumabIBA 02/2024 - 01/2019
6	ChemokinesIBA 01/2024 - 08/2007
6	Plasma KallikreinIBA 11/2023 - 01/2016
6	Interleukin-6 (Interleukin 6)IBA 08/2023 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2010
6	AntigensIBA 01/2021 - 01/2012
6	desloratadine (Aerius)FDA LinkGeneric 12/2019 - 03/2009
6	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 08/2006
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 10/2008
5	NeuropeptidesIBA 01/2022 - 08/2006
5	AntibodiesIBA 07/2021 - 07/2011
5	Substance PIBA 01/2021 - 06/2007
4	berotralstatIBA 12/2023 - 01/2018
4	C-Reactive ProteinIBA 08/2023 - 05/2013
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023 - 01/2021
4	Interleukin-33IBA 12/2022 - 04/2012
4	Bradykinin B2 ReceptorIBA 01/2022 - 04/2010
4	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2022 - 01/2018
3	montelukast (Singulair)FDA Link 12/2024 - 09/2015
3	Iodide Peroxidase (Deiodinase)IBA 11/2023 - 04/2011
3	Interleukin-1 (Interleukin 1)IBA 03/2023 - 10/2012
3	Epinephrine (Adrenaline)FDA LinkGeneric 01/2023 - 01/2022
3	InflammasomesIBA 11/2022 - 10/2012
3	Immunoglobulin A (IgA)IBA 01/2021 - 12/2020
3	canakinumab FDA Link 01/2020 - 09/2013
3	levocetirizine FDA LinkGeneric 12/2019 - 05/2013
3	fexofenadine (Allegra)FDA LinkGeneric 12/2019 - 05/2013
3	Chymases (Chymase)IBA 02/2014 - 08/2007
3	Interleukin-10 (Interleukin 10)IBA 01/2012 - 08/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007 - 01/2003
2	Dapsone FDA Link 12/2024 - 09/2015
2	Histamine Receptors (Histamine Receptor)IBA 02/2024 - 01/2011
2	LipopolysaccharidesIBA 01/2024 - 01/2012
2	bilastineIBA 01/2024 - 12/2019
2	sebetralstatIBA 11/2023 - 09/2023
2	Interferon Type IIBA 08/2023 - 01/2021
2	IgE Receptors (Fc epsilon RI)IBA 02/2023 - 12/2020
2	Therapeutic UsesIBA 01/2023 - 01/2021
2	remibrutinibIBA 12/2022 - 01/2022
2	SteroidsIBA 11/2022 - 07/2014
2	FibrinIBA 10/2022 - 04/2021

Therapy/Procedure

46	Therapeutics 12/2024 - 01/2007
4	Injections 10/2023 - 09/2006
2	Transplantation 01/2024 - 10/2016
2	Aftercare (After-Treatment) 06/2023 - 11/2006